Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Survival benefit for long-term atrasentan in HRPCa

June 3, 2002

Antitumor xanthone compounds obtained from Streptomyces

June 3, 2002

New prenyltransferase inhibitors in early development at Merck

June 3, 2002

MLN-518 enters phase I in AML

May 31, 2002

Single-dose palonosetron provides prolonged relief from CINV

May 31, 2002

LymphoRad targets B-cells and B-cell tumors and exerts antitumor activity in preclinical studies

May 31, 2002

Phase I results support further development of ABX-EGF for cancer

May 31, 2002

Potent inhibitor of Jak family protein tyrosine kinases discovered at Merck

May 31, 2002

Early clinical data for DRF-1042 presented at ASCO

May 31, 2002

BMS patent describes DNA topoisomerase I inhibitors

May 31, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...